Skip to main content

Applied Dna Scns(APDN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Latest News

Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
Business Wire - Thu May 12, 3:05PM CDT
Business Wire
Thu May 12, 3:05PM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, today announced consolidated financial results for the second quarter of fiscal 2022, ended March 31, 2022.
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
Business Wire - Mon May 9, 9:00AM CDT
Business Wire
Mon May 9, 9:00AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in cell-free, enzymatic DNA production, today announced that it will report fiscal 2022 second quarter financial results after market close on Thursday, May 12,...
Applied DNA Awarded NYC-Based ‘Return-to-Office’
Business Wire - Wed Apr 6, 8:00AM CDT
Business Wire
Wed Apr 6, 8:00AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has been awarded a...
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
Business Wire - Wed Mar 23, 11:00AM CDT
Business Wire
Wed Mar 23, 11:00AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in cell-free, enzymatic DNA production, today announced that CEO Dr. James A. Hayward is invited to present at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by...
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
Business Wire - Mon Mar 14, 7:00AM CDT
Business Wire
Mon Mar 14, 7:00AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, and Spindle Biotech Inc. (“Spindle Biotech”), a company focused on the development of a novel, high yield, and low-cost RNA production...
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
Business Wire - Thu Feb 24, 4:50PM CST
Business Wire
Thu Feb 24, 4:50PM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with an institutional investor of...
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
Business Wire - Tue Feb 22, 7:00AM CST
Business Wire
Tue Feb 22, 7:00AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has entered into a securities purchase agreement with an institutional investor, providing for...
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
Business Wire - Thu Feb 17, 8:00AM CST
Business Wire
Thu Feb 17, 8:00AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, and its program development partner, EvviVax, S.R.L. ("Evvivax"), today announced...
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
Business Wire - Thu Feb 10, 3:05PM CST
Business Wire
Thu Feb 10, 3:05PM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced consolidated financial results for the first quarter of fiscal...
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
Business Wire - Thu Feb 3, 9:00AM CST
Business Wire
Thu Feb 3, 9:00AM CST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)- based DNA manufacturing and nucleic acid-based technologies, today announced that it will report fiscal 2022 first quarter...